Quercetin Promotes Abdominal Aortic Aneurysm Regression Through the RAGE/PI3K/AKT/mTOR Axis

被引:0
|
作者
Yang, Xin [1 ]
Wang, Ying [1 ]
Xin, Guangyu [1 ]
Li, Jie [1 ]
Xu, Lei [1 ]
Zhang, Guohua [2 ]
Yang, Haotian [2 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 2, Qiqihar 161006, Peoples R China
[2] Heilongjiang Acad Agr Sci, Branch Anim Husb & Vet Branch, Qiqihar, Peoples R China
关键词
quercetin; RAGE; abdominal aortic aneurysm; elastase; RAGE/PI3K/AKT/mTOR; SUPPRESSES; THERAPY; CANCER; RAGE;
D O I
10.1177/1934578X241286438
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Abdominal aortic aneurysms (AAA) are a common critical cardiovascular disease with high morbidity and mortality rates. Quercetin, a flavonoid and a traditional Chinese medicinal ingredient commonly found in vegetables and fruits, has a favorable inhibitory effect on experimental aneurysms without side effects. This study aimed to model elastase AAA and investigate the mechanism of action of quercetin in alleviating AAA. Methods: Quercetin was administered at a dose of 60 mg/kg once daily starting on the day of AAA induction for 5 weeks. The therapeutic effect of quercetin on AAA was demonstrated using biochemical assays, observation of pathological tissue sections, Elastic Van Gieson staining, immunohistochemistry, molecular docking simulations, and Western blot protein validation. Results: Our study showed that quercetin treatment significantly alleviated abdominal aortic vessel wall dilatation, elastin degradation and adhesion to surrounding tissues caused by elastase. Additionally, quercetin significantly inhibited the mRNA and protein expression of the receptor for advanced glycation end products(RAGE)/ phosphatidylinositol 3-kinase (PI3K)/ phosphatidylinositol 3-kinase (AKT) / mammlian target of rapamycin (mTOR) pathway. Conclusion: Quercetin can alleviate abdominal aortic injury caused by elastase via RAGE/PI3K/AKT/mTOR and provide experience in clinical use.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Natural flavonoid luteolin promotes the differentiation of porcine myoblasts through activation of PI3K/Akt/mTOR signaling
    Guan, Xin
    Pan, Zihe
    Xu, Zhuoya
    Zhang, Sidun
    Tang, Haohao
    Du, Guocheng
    Zhou, Jingwen
    FOOD BIOSCIENCE, 2022, 47
  • [42] A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway
    Ling, Li
    Yuan, Xiao
    Liu, Xia
    Pei, Wenjun
    Li, Ranran
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [43] IMMT promotes hepatocellular carcinoma formation via PI3K/AKT/mTOR pathway
    Wang, Jiabei
    Zhang, Yunguang
    Sun, Linmao
    Liu, Yao
    ONCOLOGIE, 2023, 25 (06) : 691 - 703
  • [44] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [45] RAS Signaling in the PI3K/AKT/MTOR Pathway
    Nussinov, Ruth
    Zhang, Mingzhen
    Jang, Hyunbum
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 51A - 51A
  • [46] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [47] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [48] PI3K/AKT/MTOR SIGNALING IN OLIGODENDROCYTE DIFFERENTIATION
    Wood, T. L.
    Tyler, W. A.
    Gangoli, N.
    Gokina, P.
    Kim, H. A.
    Covey, M.
    Levison, S. W.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 141 - 141
  • [49] THE PI3K/AKT MTOR PATHWAY IN OLIGODENDROCYTE DIFFERENTIATION
    Wood, T.
    Tyler, W.
    Gangoli, N.
    Gokina, P.
    Kim, H.
    Covey, M.
    Levison, S.
    GLIA, 2009, 57 (13) : S20 - S20
  • [50] PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
    Mazzoletti, M.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4433 - 4447